MariaL.YatacoMD

Gastroenterology • Jacksonville, FL

Hepatology & Liver Transplantation

Assistant Professor of Medicine, Mayo Medical School

Join to view full profile

Dr. Yataco is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Yataco's full profile

Already have an account?

Office
4500 San Pablo Rd S
Jacksonville, FL 32224
Phone+1 904-953-2000

Education & Training

University of TennesseeFellowship, Gastroenterology, 2008 - 2011
Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Transplant Hepatology, 2006 - 2007
Cleveland Clinic Foundation (Florida)Residency, Internal Medicine, 1999 - 2002
Cayetano Heredia UniversityClass of 1998

Certifications & Licensure

AZ State Medical License 2023 - 2026
FL State Medical License 2001 - 2026
AL State Medical License 2024 - 2025
OH State Medical License 2001 - 2002
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology
American Board of Internal Medicine Transplant Hepatology

Publications & Presentations

PubMed

1 citations
Efficacy of a two-dose hepatitis B vaccination with a novel immunostimulatory sequence adjuvant (Heplisav-B) on patients with chronic liver disease: a retrospective st...
Joshua Y Kwon, Nader Daoud, Hassan Ghoz, Maria L Yataco, Francis A Farraye
Translational Gastroenterology and Hepatology. 2023-01-01
Management of the Incidental Liver Lesion.
Maria L. Yataco, Andrew W. Bowman, Andrew P. Keaveny
The American Journal of Gastroenterology. 2021-05-01
19 citations
Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort.
Kristopher P. Croome, David D. Lee, Sarah Croome, Raouf E. Nakhleh, Peter A. Senada
Liver Transplantation. 2019-10-01

Press Mentions

The $35 Billion Race to Cure a Silent Killer That Affects 30 Million AmericansNovember 23rd, 2019
NASH: The Next Big, Fatty Drug for the Pharmaceutical IndustryMay 9th, 2019
New Liver, New OutlookDecember 12th, 2018

Other Languages

Spanish